Infectious module pharmacology

Reading File
This is a broad topic. Let me clarify what you need before diving in.
Asking for Preferences

What aspect of infectious disease pharmacology do you want covered? · What level of detail do you need?

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Good — I have pharmacology and microbiology textbooks. Now let me search across multiple drug classes simultaneously.
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
I see block 12 is on toxicology — the infectious pharmacology content is in a different block of Katzung's. Let me read the relevant blocks directly.
Reading File
Reading File
The blocks I need are in different parts. Let me directly read the antibiotic, antifungal sections from Katzung and Lippincott.
Finding Sources
Finding Sources
I've hit my DB query limit. I have enough textbook context from the readings. Let me now read the key infectious pharmacology sections from Katzung block 9 (where penicillin and antibiotics are, around line 1079) and the Lippincott pharmacology book.
Reading File
Reading File
Excellent — I have rich content from Katzung block 9. Let me read more of this block to cover macrolides, fluoroquinolones, aminoglycosides, antifungals, and antiparasitics.
Reading File
Reading File
I now have comprehensive content covering all the major antibiotic classes. I have enough from the textbooks to synthesize a complete overview. Let me now compile the full infectious disease pharmacology overview.Here is a comprehensive overview of Infectious Module Pharmacology, organized by drug class.

Infectious Disease Pharmacology


SECTION 1: ANTIBACTERIALS

1.1 Beta-Lactams — Cell Wall Synthesis Inhibitors

Beta-lactams all share a beta-lactam ring and inhibit transpeptidase (PBP — penicillin-binding proteins), blocking the final cross-linking step of peptidoglycan synthesis → osmotic lysis and bactericidal death.
Mechanism of Resistance:
  • β-lactamase production (cleaves the ring)
  • Altered PBPs (e.g., MRSA's mecA gene → PBP2a with low affinity)
  • Reduced outer membrane permeability (gram-negatives)
  • Efflux pumps

A. Penicillins

DrugKey FeaturesUses
Penicillin G (IV)Drug of choice for susceptible streptococci, meningococci, T. pallidum, Actinomyces, non-β-lactamase staphylococciSyphilis (benzathine PCN G 2.4M units IM ×1–3 wks); streptococcal pharyngitis, pneumococcal infections
Penicillin V (oral)Narrow spectrum, poor bioavailabilityMinor gram-positive infections
Benzathine PCN GLong-acting IM depot; low but prolonged levelsSyphilis, rheumatic fever prophylaxis
Nafcillin / Oxacillinβ-lactamase resistant (anti-staphylococcal)MSSA bacteremia, endocarditis (8–12 g/day IV)
DicloxacillinOral anti-staphylococcalMild–moderate skin/soft tissue MSSA infections
AmpicillinExtended-spectrum, susceptible to β-lactamaseListeria, enterococci, H. influenzae (if susceptible)
AmoxicillinBetter oral bioavailability than ampicillin; not affected by foodCommunity-acquired pneumonia, H. pylori, otitis media
Amoxicillin-clavulanate+ β-lactamase inhibitorAnimal bites, sinusitis, community-acquired pneumonia
Piperacillin-tazobactamExtended antipseudomonal spectrumHospital-acquired infections, febrile neutropenia
⚠️ Allergy: ~1–10% have penicillin allergy. Cross-reactivity with cephalosporins ~1–2% (not 10% as classically taught). Anaphylaxis requires avoidance; skin testing can clarify.

B. Cephalosporins

Grouped by generation; each generation gains better gram-negative coverage and loses some gram-positive activity:
GenerationExamplesSpectrum / Notes
1stCefazolin, CephalexinStrong gram-positive (MSSA); surgical prophylaxis, UTI
2ndCefuroxime, CefoxitinAdded H. influenzae; Cefoxitin covers anaerobes (B. fragilis)
3rdCeftriaxone, Cefotaxime, CeftazidimeExcellent gram-negative; Ceftriaxone: meningitis, gonorrhea; Ceftazidime: Pseudomonas
4thCefepimeExtended gram-negative including Pseudomonas + gram-positive
5thCeftarolineCovers MRSA (only cephalosporin with MRSA activity)

C. Carbapenems

Broadest spectrum beta-lactams — resistant to most β-lactamases (except carbapenemases).
DrugNotes
Imipenem-cilastatinCilastatin prevents renal dehydropeptidase degradation; seizures at high doses
MeropenemCNS infections; less seizure risk
ErtapenemNo Pseudomonas/Acinetobacter coverage; once-daily dosing
DoripenemPseudomonas coverage
Carbapenem-resistant organisms (CRE): treated with ceftazidime-avibactam, meropenem-vaborbactam, or cefiderocol.

D. Monobactams

  • Aztreonam: Gram-negative only (including Pseudomonas); safe in penicillin allergy (no cross-reactivity except with ceftazidime).

1.2 Glycopeptides — Cell Wall (Transglycosylation) Inhibitors

Mechanism: Bind D-Ala–D-Ala terminus of peptidoglycan precursors → block transglycosylase AND transpeptidase (different from beta-lactams).
DrugKey Points
VancomycinDrug of choice for MRSA, C. diff (oral only for GI). IV: bacteremia, endocarditis, meningitis. Monitor troughs (15–20 mcg/mL) or AUC/MIC. Adverse: Red Man Syndrome (infusion-related histamine release), nephrotoxicity, ototoxicity
TeicoplaninSimilar to vancomycin; longer half-life
Dalbavancin / OritavancinLong-acting lipoglycopeptides; single or once-weekly dosing for ABSSSI
Resistance: VRE (vancomycin-resistant enterococci) — D-Ala–D-Ala → D-Ala–D-Lac → vancomycin cannot bind.

1.3 Aminoglycosides — Protein Synthesis Inhibitors (30S)

Mechanism: Bind 30S ribosomal subunit → misreading of mRNA → insertion of wrong amino acids → faulty membrane proteins → increased membrane permeability → further drug entry → bactericidal.
Key drugs: Gentamicin, Tobramycin, Amikacin, Streptomycin, Neomycin, Plazomicin (next-gen)
Spectrum: Aerobic gram-negative bacilli (E. coli, Klebsiella, Pseudomonas); synergistic with beta-lactams vs. enterococci and streptococci.
Adverse Effects (major):
  • Nephrotoxicity: Proximal tubule damage; monitor creatinine
  • Ototoxicity: Cochlear (tobramycin) or vestibular (gentamicin, streptomycin); irreversible
  • Neuromuscular blockade: Avoid in myasthenia gravis
Dosing: Once-daily (extended-interval) preferred — exploits concentration-dependent killing and post-antibiotic effect; reduces nephrotoxicity.
Resistance: Enzymatic modification (acetyltransferases, phosphotransferases, nucleotidyltransferases) — plazomicin is unaffected by most of these.

1.4 Tetracyclines — Protein Synthesis Inhibitors (30S)

Mechanism: Bind 30S ribosome reversibly → block aminoacyl-tRNA binding → bacteriostatic.
DrugNotes
DoxycyclineDrug of choice among tetracyclines; twice daily; food does not impair absorption; used in atypical pneumonia, Lyme disease, Rocky Mountain Spotted Fever, cholera, malaria prophylaxis
MinocyclineTwice daily; used in MRSA skin infections, acne
Tigecycline3rd-gen glycylcycline; IV only; broad spectrum including MRSA, VRE, MDR gram-negatives; not for Pseudomonas or Proteus; bacteriostatic
EravacyclineIV; complicated intra-abdominal infections; MDR coverage
OmadacyclineIV and oral; CAP and ABSSSI; must be taken fasting (food markedly reduces absorption)
Adverse Effects: GI irritation, esophageal ulceration (take with water and stay upright), photosensitivity, dental staining + bone deposition (avoid in children <8 years and pregnancy), hepatotoxicity at high IV doses.
Key drug interactions: Chelation with divalent cations (Ca²⁺, Mg²⁺, Fe²⁺, Al³⁺) — separate by 2–4 hours.

1.5 Macrolides / Azalides — Protein Synthesis Inhibitors (50S)

Mechanism: Bind 50S ribosomal subunit (23S rRNA) → block peptide elongation by blocking translocation → bacteriostatic.
DrugNotes
ErythromycinOriginal macrolide; GI prokinetic side effect (motilin agonist); multiple CYP3A4 interactions; QT prolongation
ClarithromycinBetter GI tolerance; H. pylori triple therapy; MAC prophylaxis; strong CYP3A4 inhibitor
AzithromycinAzalide (15-membered ring); concentrated intracellularly; long t½ (3–5 days) → 5-day course for community-acquired pneumonia; Chlamydia, MAC prophylaxis; QT prolongation; less CYP interactions
Spectrum: Atypicals (Mycoplasma, Chlamydia, Legionella), gram-positive cocci, H. pylori, Bordetella, MAC.
Resistance: Methylation of 23S rRNA (erm genes) → cross-resistance among macrolides.

1.6 Clindamycin — Protein Synthesis Inhibitors (50S)

Mechanism: Binds 50S ribosome (same site as macrolides, lincosamide binding site). Spectrum: Anaerobes (B. fragilis), gram-positive cocci including MSSA and MRSA (skin). Uses: Skin/soft tissue infections, aspiration pneumonia, pelvic infections, malaria (with quinine). Adverse: C. difficile colitis (historically associated, though any antibiotic can cause it).

1.7 Linezolid / Oxazolidinones — Protein Synthesis Inhibitors (50S)

Mechanism: Binds 50S ribosome at 23S rRNA → prevents formation of the 70S initiation complex → unique mechanism, no cross-resistance. Spectrum: MRSA, VRE, MDR-TB (as linezolid). Adverse: Myelosuppression (especially thrombocytopenia with prolonged use), serotonin syndrome (MAO inhibition — avoid with SSRIs/SNRIs), peripheral neuropathy, optic neuritis.

1.8 Fluoroquinolones — DNA Synthesis Inhibitors

Mechanism: Inhibit DNA gyrase (topoisomerase II, gram-negatives) and topoisomerase IV (gram-positives) → bactericidal (concentration-dependent killing).
GenerationExamplesSpectrum
1stNalidixic acidGram-negative UTI only (historical)
2ndCiprofloxacin, NorfloxacinGram-negatives, Pseudomonas (cipro); UTI, traveler's diarrhea
3rdLevofloxacinGram-negatives + gram-positives + atypicals; "respiratory fluoroquinolone"
4thMoxifloxacinAnaerobes added; best atypical and gram-positive coverage; NOT for UTI (no urinary excretion)
Adverse Effects: Tendon rupture (especially Achilles; fluoroquinolone warning), QT prolongation, C. diff, cartilage damage (avoid <18 years), CNS effects (seizures, confusion), photosensitivity, peripheral neuropathy.
Resistance: Mutations in gyrA/parC genes; efflux pumps — highly prevalent in gram-negatives.

1.9 Sulfonamides & Trimethoprim — Folate Synthesis Inhibitors

Mechanism:
  • Sulfonamides (e.g., sulfamethoxazole): PABA analogs → inhibit dihydropteroate synthase (bacterial folate synthesis)
  • Trimethoprim: inhibits dihydrofolate reductase → blocks THF production
  • TMP-SMX (Co-trimoxazole): Sequential double blockade → synergistic bactericidal effect
Uses: UTI, Pneumocystis jirovecii pneumonia (PCP) prophylaxis and treatment (high-dose), Nocardia, Toxoplasma (with pyrimethamine), Stenotrophomonas.
Adverse Effects: Sulfa allergy (rash, Stevens-Johnson syndrome), hemolytic anemia in G6PD deficiency, kernicterus (avoid in neonates), nephrotoxicity, myelosuppression (high doses).

1.10 Nitroimidazoles — DNA Damage

Metronidazole: Activated by bacterial/protozoal nitroreductases → forms toxic free radicals → DNA strand breaks → bactericidal/protozoacidal. Uses: Anaerobes (B. fragilis, C. difficile — oral), H. pylori triple therapy, Giardia, Trichomonas, Entamoeba. Adverse: Disulfiram-like reaction with alcohol, metallic taste, peripheral neuropathy, CNS toxicity at high doses.

1.11 Polymyxins — Cell Membrane Disruptors

Polymyxin B / Colistin (Polymyxin E): Cationic peptides → bind LPS in gram-negative outer membrane → disrupt membrane integrity → leak of intracellular contents → bactericidal. Uses: Last resort for MDR gram-negatives — Acinetobacter, Pseudomonas, KPC-producing Klebsiella. Adverse: Nephrotoxicity (dose-limiting), neurotoxicity (paresthesias, ataxia).

1.12 Miscellaneous Antibiotics

DrugMechanismUsesNotes
DaptomycinLipopeptide; binds gram-positive membranes → depolarization → cell deathMRSA bacteremia, endocarditis, VREInactivated by pulmonary surfactant — do NOT use for pneumonia. Monitor CPK (myopathy)
RifampinInhibits bacterial DNA-dependent RNA polymeraseTB, leprosy, Staphylococcal infections (combo), meningococcal prophylaxisPotent CYP inducer — numerous drug interactions; turns secretions orange-red
NitrofurantoinForms reactive intermediates damaging DNA/proteinsUncomplicated UTIConcentrates in urine only; avoid if CrCl <30; pulmonary toxicity with chronic use
Chloramphenicol50S (23S rRNA) inhibitor; blocks peptidyl transferaseTyphoid, meningitis (pen-allergic), Rocky Mountain Spotted FeverGrey baby syndrome, aplastic anemia — rarely used in developed countries
FosfomycinInhibits MurA (first step in peptidoglycan synthesis)Uncomplicated UTI (single 3g dose), ESBL infectionsOral single dose for UTI; IV for MDR gram-negatives

SECTION 2: ANTIMYCOBACTERIALS

Tuberculosis — First-Line Drugs (RIPE)

DrugMechanismKey Adverse Effects
Rifampin (R)Inhibits RNA polymeraseCYP inducer (drug interactions), orange secretions, hepatotoxicity
Isoniazid (I)Inhibits mycolic acid synthesis (InhA)Peripheral neuropathy (B6 deficiency → give pyridoxine), hepatotoxicity, drug-induced lupus, hemolysis in G6PD
Pyrazinamide (P)Unknown (disrupts membrane potential)Hyperuricemia, gout, hepatotoxicity
Ethambutol (E)Inhibits arabinosyltransferase (cell wall)Optic neuritis (retrobulbar) — monitor visual acuity and color discrimination
Standard regimen: 2 months RIPE (intensive) → 4 months RI (continuation).

Leprosy

  • Dapsone + RifampinClofazimine for multibacillary) — multi-drug therapy (MDT)
  • Dapsone: also causes hemolytic anemia in G6PD deficiency; methemoglobinemia

SECTION 3: ANTIVIRALS

3.1 Anti-Herpetics

DrugMechanismUses
AcyclovirNucleoside analog; phosphorylated by viral thymidine kinase → inhibits viral DNA polymerase (chain termination)HSV-1/2 (oral, genital, encephalitis), VZV
ValacyclovirProdrug of acyclovir; better oral bioavailabilityHSV-2 suppression, VZV
FamciclovirProdrug of penciclovirVZV (shingles), HSV
GanciclovirPhosphorylated by CMV UL97 kinase → viral DNA polymerase inhibitorCMV retinitis, CMV in transplant patients
ValganciclovirOral prodrug of ganciclovirCMV prophylaxis/treatment in transplant
FoscarnetDirectly inhibits viral DNA polymerase/reverse transcriptase (no activation needed)CMV (ganciclovir-resistant), HSV (acyclovir-resistant); nephrotoxic
CidofovirNucleotide analog; self-phosphorylatingCMV retinitis; severe nephrotoxicity (use with IV probenecid)
Resistance: Mutations in viral thymidine kinase (acyclovir resistance) or DNA polymerase → use foscarnet.

3.2 Anti-Influenza

DrugMechanismNotes
Oseltamivir (Tamiflu)Neuraminidase inhibitor → prevents viral release and spreadInfluenza A & B; treat within 48h of symptoms
Zanamivir (Relenza)Neuraminidase inhibitor (inhaled)Influenza A & B; caution in asthma/COPD
BaloxavirCap-dependent endonuclease inhibitor (PA subunit)Single oral dose; novel mechanism; Flu A & B
Amantadine / RimantadineM2 ion channel inhibitor → blocks uncoatingInfluenza A only; not used currently due to high resistance

3.3 Antiretrovirals (HIV)

HIV requires combination therapy (ART — antiretroviral therapy) targeting multiple steps. Current standard: 2 NRTIs + 1 INSTI (integrase inhibitor).
ClassExamplesMechanismKey Toxicities
NRTIs (Nucleoside RT inhibitors)Zidovudine (AZT), Lamivudine (3TC), Emtricitabine, Tenofovir, AbacavirCompetitive inhibitors of reverse transcriptase; chain terminators (no 3'-OH)Zidovudine: bone marrow suppression, anemia; Tenofovir: nephrotoxicity, bone loss; Abacavir: hypersensitivity (HLA-B*5701 screening required)
NNRTIs (Non-nucleoside RT inhibitors)Efavirenz, Nevirapine, Rilpivirine, EtravirineBind allosteric site on reverse transcriptaseEfavirenz: CNS effects (vivid dreams, dizziness), teratogenic; Nevirapine: hepatotoxicity, rash
PIs (Protease inhibitors)Ritonavir, Darunavir, Atazanavir, LopinavirInhibit HIV aspartyl protease → immature non-infectious virionsLipodystrophy, dyslipidemia, hyperglycemia; most boosted with ritonavir (CYP3A4 inhibitor)
INSTIs (Integrase inhibitors)Dolutegravir, Raltegravir, Bictegravir, CabotegravirBlock HIV integrase → prevent viral DNA integration into host genomeGenerally well-tolerated; dolutegravir: neural tube defects (concern in early pregnancy)
Fusion inhibitorsEnfuvirtideBinds gp41 → prevents membrane fusionInjection site reactions; SC only
Entry inhibitors (CCR5 antagonists)MaravirocBlock CCR5 co-receptor on CD4 T cellsOnly active against CCR5-tropic virus (requires tropism testing); hepatotoxicity
PrEP (Pre-Exposure Prophylaxis): Tenofovir-emtricitabine (Truvada) or tenofovir alafenamide-emtricitabine (Descovy); long-acting cabotegravir IM injection monthly/every 2 months.
PMTCT: Zidovudine reduces perinatal HIV transmission by 65–75%.

3.4 Anti-Hepatitis Drugs

DrugTargetUses
Entecavir / TenofovirHBV reverse transcriptaseChronic hepatitis B (first-line)
Interferon-α (pegylated)Immunomodulatory; antiviralChronic HBV, HCV (now replaced by DAAs)
SofosbuvirHCV NS5B (RNA-dependent RNA polymerase) inhibitorHCV (all genotypes in combination); >95% SVR
NS5A inhibitorsLedipasvir, VelpatasvirHCV; used in combination with sofosbuvir
NS3/4A inhibitors (PIs)Glecaprevir, GrazoprevirHCV
Current standardSofosbuvir/velpatasvir (Epclusa) or Glecaprevir/pibrentasvir (Mavyret)Pan-genotypic HCV cure; 8–12 weeks

3.5 Antiviral Targets Summary

TargetDrug ClassVirus
DNA polymeraseAcyclovir, ganciclovir, cidofovirHSV, CMV, VZV
Reverse transcriptaseNRTIs, NNRTIsHIV, HBV
ProteasePIsHIV, HCV
IntegraseINSTIsHIV
NeuraminidaseOseltamivir, zanamivirInfluenza
NS5B RNA polymeraseSofosbuvirHCV
NS5ALedipasvir, velpatasvirHCV

SECTION 4: ANTIFUNGALS

Overview of Antifungal Targets

TargetDrug Class
Ergosterol (membrane)Polyenes (bind ergosterol), Azoles (inhibit synthesis), Allylamines
Glucan synthesisEchinocandins
Nucleic acid synthesisFlucytosine

4.1 Polyenes

Mechanism: Bind ergosterol in fungal cell membrane → form pores → leakage of K⁺, H⁺, sugars → cell death (fungicidal).
DrugUsesToxicity
Amphotericin B (deoxycholate)Broadest spectrum antifungal; Aspergillus, Candida, Cryptococcus, Histoplasma, Blastomyces, Coccidioides, MucorNephrotoxicity (dose-limiting, tubular acidosis, hypokalemia), infusion-related reactions (fever, rigors, hypotension — "shake and bake"), anemia
Liposomal AmB (AmBisome)Same spectrum; reduced nephrotoxicityLess nephrotoxic; preferred in renal impairment
NystatinTopical/oral onlyCandida (oral thrush, vaginal, skin) — too toxic for systemic use

4.2 Azoles

Mechanism: Inhibit CYP51 (lanosterol 14α-demethylase) → block ergosterol synthesis → depletion of ergosterol + accumulation of toxic methylated sterols → fungistatic (or fungicidal for some).
DrugRouteSpectrumKey Notes
FluconazoleOral/IVCandida (not C. krusei or C. glabrata), CryptococcusFirst-line for Candida infections; excellent CNS penetration (cryptococcal meningitis maintenance); CYP2C9/3A4 inhibitor
ItraconazoleOralHistoplasma, Blastomyces, Aspergillus (less reliable), dermatophytes, SporothrixPoor CNS penetration; requires acid for absorption; negative inotrope — avoid in heart failure
VoriconazoleOral/IVAspergillus (drug of choice), Candida, Fusarium, ScedosporiumVisual disturbances (hallucinations, photopsia); hepatotoxicity; phototoxicity; drug interactions (CYP2C19 inhibitor); TDM recommended
PosaconazoleOral/IVAspergillus, Mucor/Rhizopus (only azole with Mucorales coverage)Prophylaxis in high-risk patients (AML, BMT); requires high-fat meal for suspension form
IsavuconazoleOral/IVAspergillus, MucorAlternative for Mucorales; fewer drug interactions; shortens QTc (opposite of other azoles)

4.3 Echinocandins

Mechanism: Non-competitive inhibitors of β-(1,3)-glucan synthase → block fungal cell wall synthesis (fungal-specific target — mammalian cells lack this enzyme) → fungicidal against Candida; fungistatic against Aspergillus.
DrugNotes
CaspofunginFirst-line alternative for invasive Candida, Aspergillus; used when azole-resistant Candida
MicafunginPreferred for Candida prophylaxis in stem cell transplant
AnidulafunginIV; minimal drug interactions; no hepatic metabolism
Advantages: Minimal nephrotoxicity; minimal drug interactions; can be used in renal impairment. Limitations: No CNS penetration (not for Cryptococcal meningitis); IV only; expensive.

4.4 Allylamines

Terbinafine: Inhibits squalene epoxidase → squalene accumulation → fungicidal. Uses: Dermatophytes (onychomycosis, tinea), oral form for nail infections. Adverse: Hepatotoxicity, taste disturbances, CYP2D6 inhibitor.

4.5 Flucytosine (5-FC)

Mechanism: Enters fungal cells → converted to 5-fluorouracil → inhibits thymidylate synthase + incorporated into RNA → disrupts nucleic acid synthesis. Uses: Cryptococcal meningitis (combined with amphotericin B — synergistic; never as monotherapy due to rapid resistance emergence). Adverse: Myelosuppression, hepatotoxicity, GI toxicity — narrow therapeutic index; monitor levels.

SECTION 5: ANTIPARASITICS

5.1 Antimalarials

DrugMechanismUsesKey Toxicity
ChloroquineAccumulates in food vacuole → inhibits heme polymerase → toxic heme accumulatesP. vivax, P. ovale, P. malariae, sensitive P. falciparumRetinopathy (chronic), QT prolongation; most P. falciparum is resistant
HydroxychloroquineSame as chloroquineRheumatologic uses; some malariaRetinopathy with long-term use
PrimaquineDisrupts mitochondriaEliminates liver hypnozoites of P. vivax & P. ovale (radical cure)Hemolytic anemia in G6PD deficiency — must screen first; methemoglobinemia
Artemisinin / ArtesunateIron-mediated free radical generation → damages proteinsDrug of choice for severe P. falciparum (IV artesunate); first-line in combination (ACT)Well-tolerated; neurotoxicity only with high experimental doses
MefloquineMechanism unclear (possibly heme polymerase)Prophylaxis and treatment (chloroquine-resistant P. falciparum)Neuropsychiatric effects (hallucinations, nightmares, seizures, psychosis)
Atovaquone-Proguanil (Malarone)Atovaquone disrupts mitochondrial electron transport; proguanil inhibits DHFRProphylaxis and treatment of P. falciparumGI side effects; expensive
Quinine + ClindamycinHeme polymerization inhibitor; disrupts membraneSevere malaria; BabesiaCinchonism (tinnitus, headache, nausea), hypoglycemia, QT prolongation
DoxycyclineProtein synthesis inhibitionProphylaxis (endemic areas) + adjunctive treatmentPhotosensitivity; avoid in pregnancy
Life cycle consideration: Chloroquine eliminates blood-stage parasites but does not clear liver hypnozoites (P. vivax, P. ovale) → must add primaquine for radical cure.

5.2 Antiprotozoals

DrugTarget OrganismMechanism / Notes
MetronidazoleGiardia, Trichomonas, E. histolytica, anaerobesNitro-free radical damage to DNA
TinidazoleSame as metroLonger t½; single-dose Giardia treatment
PentamidineP. jirovecii, Leishmaniasis, TrypanosomiasisDisrupts DNA; IV/inhaled; hypoglycemia, nephrotoxicity
TMP-SMXP. jirovecii (PCP)Folate inhibition (drug of choice for PCP)
AtovaquonePCP (mild-moderate), Toxoplasma prophylaxisMitochondrial electron transport inhibitor
Pyrimethamine + SulfadiazineToxoplasma gondiiFolate synthesis inhibition (double blockade); give folinic acid (leucovorin) to reduce toxicity
MelarsoprolT. brucei (African trypanosomiasis, CNS stage)Organic arsenical — inhibits enzymes; severe toxicity (encephalopathy)
Benznidazole / NifurtimoxT. cruzi (Chagas disease)Nitro radical damage
Sodium stibogluconateLeishmaniasisPentavalent antimony; inhibits energy metabolism

5.3 Anthelmintics

DrugMechanismUses
Mebendazole / AlbendazoleInhibit β-tubulin polymerization → block microtubule formation → impair glucose uptakeRoundworms (Ascaris), hookworms, pinworms, whipworm; Albendazole: also Neurocysticercosis, echinococcosis, Strongyloides
IvermectinPotentiates GABA-gated Cl⁻ channels → hyperpolarization → paralysis of parasitesOnchocerciasis ("river blindness"), strongyloidiasis, scabies, head lice, lymphatic filariasis; Mazzotti reaction (Loa loa encephalopathy if high microfilaremia)
PraziquantelIncreases membrane permeability to Ca²⁺ → spastic paralysisSchistosomiasis, cestodes (tapeworms), liver flukes (Clonorchis, Opisthorchis)
Diethylcarbamazine (DEC)Immobilizes microfilariae; immunologic clearanceLymphatic filariasis (Wuchereria, Brugia), loiasis; contraindicated in onchocerciasis
Pyrantel pamoateDepolarizing neuromuscular blockade (ACh agonist)Ascaris, pinworms, hookworms

Key Mechanisms at a Glance

CELL WALL:
  Beta-lactams → PBP inhibition (transpeptidase)
  Vancomycin → D-Ala-D-Ala binding
  Fosfomycin → MurA inhibition
  Echinocandins → β-glucan synthase inhibition (fungal)

CELL MEMBRANE:
  Polymyxins → LPS disruption (gram-negatives)
  Amphotericin B → Ergosterol binding (fungal)
  Daptomycin → Depolarization (gram-positives)

PROTEIN SYNTHESIS:
  30S: Aminoglycosides (bactericidal), Tetracyclines (bacteriostatic)
  50S: Macrolides, Clindamycin, Linezolid, Chloramphenicol

DNA/RNA SYNTHESIS:
  Fluoroquinolones → Topoisomerase II/IV inhibition
  Rifampin → RNA polymerase inhibition
  Metronidazole → DNA strand breaks
  Nitroimidazoles (antifungal: flucytosine → 5-FU → thymidylate synthase)

FOLATE SYNTHESIS:
  Sulfonamides → Dihydropteroate synthase
  Trimethoprim → Dihydrofolate reductase
  Pyrimethamine → DHFR (antiprotozoal)

ERGOSTEROL (Antifungal):
  Azoles → Lanosterol 14α-demethylase (CYP51)
  Polyenes → Bind ergosterol (pore formation)
  Allylamines → Squalene epoxidase

Common Exam Mnemonics

MnemonicMeaning
RIPETB drugs: Rifampin, Isoniazid, Pyrazinamide, Ethambutol
"FACT"Antifungals: Fluconazole, Azoles, Caspofungin, Terbinafine
"Every Good Boy Does Fine"Erythromycin, Gentamicin, Bacteriostatic vs. bactericidal context
"OGLE"Oseltamivir, Ganciclovir, Lamivudine, Entecavir (antivirals with specific targets)
Red Man SyndromeVancomycin (infusion-rate dependent — not true allergy; slow infusion rate)
G6PD check beforePrimaquine, Dapsone, Nitrofurantoin
HLA-B*5701 before AbacavirHypersensitivity screening

Sources: Katzung's Basic and Clinical Pharmacology 16th Ed., Jawetz Melnick & Adelberg's Medical Microbiology 28th Ed., Goodman & Gilman's Pharmacological Basis of Therapeutics, Lippincott Illustrated Reviews: Pharmacology.This covers the full Infectious Module Pharmacology in detail. Here's a quick navigation guide to the content above:

What's Covered

SectionTopics
1. AntibacterialsBeta-lactams (PCN, cephalosporins, carbapenems, monobactams), Glycopeptides (vancomycin), Aminoglycosides, Tetracyclines, Macrolides, Clindamycin, Linezolid, Fluoroquinolones, TMP-SMX, Metronidazole, Polymyxins, Daptomycin, Rifampin, Nitrofurantoin
2. AntimycobacterialsTB (RIPE regimen), Leprosy (Dapsone/Rifampin/Clofazimine)
3. AntiviralsAnti-herpetics (acyclovir family, ganciclovir, foscarnet), Anti-influenza (oseltamivir, baloxavir), HIV/ART (NRTIs, NNRTIs, PIs, INSTIs, fusion/entry inhibitors), Anti-hepatitis (HBV & HCV DAAs)
4. AntifungalsPolyenes (amphotericin B), Azoles (fluconazole → posaconazole), Echinocandins (caspofungin), Allylamines (terbinafine), Flucytosine
5. AntiparasiticsAntimalarials (chloroquine, artesunate, primaquine, mefloquine), Antiprotozoals (metronidazole, pyrimethamine), Anthelmintics (albendazole, ivermectin, praziquantel)
Let me know if you want any section drilled deeper — e.g., resistance mechanisms, drug interactions, specific clinical cases, or a printable summary table.

Teach for a beginner

Infectious Disease Pharmacology — Beginner's Guide 🧫

Let's start from zero. No jargon without explanation. Think of this as a story.

🌍 The Big Picture First

When a germ (bacteria, virus, fungus, or parasite) invades your body, you need a drug that can kill it or stop it from growing — WITHOUT seriously harming your own cells.
This is the core challenge of infectious disease pharmacology:
"How do we kill the invader without killing the patient?"
The answer: find something the germ has that humans don't.

🔑 The Golden Rule

Every antibiotic/antiviral/antifungal exploits a difference between the microbe and human cells.
MicrobeWhat it has that humans don'tDrug that targets it
BacteriaCell wall (peptidoglycan)Penicillin, Vancomycin
Bacteria70S ribosome (ours are 80S)Tetracyclines, Aminoglycosides
BacteriaMakes its own folateSulfonamides, TMP
FungiErgosterol in membrane (we have cholesterol)Amphotericin B, Azoles
VirusesReverse transcriptaseNRTIs, NNRTIs (HIV drugs)
ParasitesSpecial enzymes / structuresChloroquine, Ivermectin
This table is the foundation of everything. Keep coming back to it.

PART 1: ANTIBIOTICS (Drugs that kill bacteria)


🧱 Chapter 1: The Bacterial Cell Wall — and How to Destroy It

First, understand what a cell wall is

Imagine a bacterium as a water balloon inside a suit of armor. The armor is the cell wall — made of a mesh-like material called peptidoglycan. Without it, the bacteria explodes from internal pressure.
Our cells have NO cell wall. So if we target the wall — we hurt the bacteria, not us.

🔵 Beta-Lactam Antibiotics (The most important antibiotic family)

How they work — simple version:
Beta-lactams handcuff the "construction workers" (enzymes called PBPs) that build the cell wall. No construction → wall falls apart → bacteria bursts.
The "beta-lactam" is just the chemical ring in the drug that does the handcuffing.

The Family Tree of Beta-Lactams:

Beta-Lactams
├── Penicillins        → Original, narrow
├── Cephalosporins     → Broader (4 generations)
├── Carbapenems        → Broadest (last resort)
└── Monobactams        → Gram-negatives only

🟦 Penicillins — "The Grandfather of Antibiotics"

Discovered accidentally by Alexander Fleming in 1928 (mold contaminating his petri dish killed bacteria).
NameRouteThink of it as…
Penicillin GIV injectionThe original; great for strep, syphilis
Penicillin VOralWeaker oral version
Benzathine PCNIM (1 injection)Slow-release depot; 1 shot cures strep throat, 1–3 shots for syphilis
AmoxicillinOralThe "everyday penicillin" — ear infections, strep, H. pylori
Amoxicillin-Clavulanate (Augmentin)OralAmoxicillin + bodyguard against resistance
Nafcillin / OxacillinIVAnti-staph (MSSA) — the go-to for staph infections
Piperacillin-Tazobactam (PipTaz)IVHospital-grade, covers Pseudomonas
💡 Why so many penicillins? Bacteria fight back by making β-lactamase — an enzyme that breaks the beta-lactam ring. Chemists kept modifying penicillin to dodge resistance. Adding a "β-lactamase inhibitor" (like clavulanate) is like adding a bodyguard that neutralizes the bacteria's weapon.

🟦 Cephalosporins — "Penicillin's Cousins, Getting Stronger Each Generation"

Same mechanism as penicillins, just modified to hit a wider range of bacteria.
GenerationExampleKey feature
1stCefazolin (IV), Cephalexin (oral)Best gram-positive coverage; surgical prophylaxis
2ndCefuroxime, CefoxitinAdded gram-negatives; Cefoxitin covers anaerobes
3rdCeftriaxone, CeftazidimeGreat gram-negatives; ceftriaxone = meningitis, gonorrhea
4thCefepimePseudomonas + gram-positives
5thCeftarolineOnly cephalosporin that kills MRSA
💡 Gram-positive vs. gram-negative — bacteria are divided by how they stain with Gram stain. Gram-positives (purple) have a thick wall; gram-negatives (pink) have a thin wall + outer membrane making them harder to penetrate. As generations increase, cephalosporins penetrate gram-negatives better.

🟦 Carbapenems — "The Big Guns"

Used when everything else fails — for resistant hospital bacteria.
DrugRemember it for…
Imipenem-CilastatinCilastatin protects it from kidney breakdown; can cause seizures at high doses
MeropenemSafer for the brain; meningitis OK
ErtapenemOnce daily; but doesn't cover Pseudomonas
⚠️ Overusing carbapenems breeds carbapenem-resistant bacteria (CRE) — some of the most dangerous infections in modern medicine.

🟦 Aztreonam — "The Loner"

  • Hits gram-negative bacteria only
  • Safe to use in patients with penicillin allergy (no cross-reaction)

🔴 Vancomycin — "The Glycopeptide Wall Destroyer"

How it works:
Instead of handcuffing the builders (like penicillin), vancomycin blocks the bricks (peptidoglycan building blocks called D-Ala–D-Ala). No bricks → no wall.
Why it matters:
  • Drug of choice for MRSA (methicillin-resistant Staph aureus)
  • Also treats C. difficile (oral form only — stays in the gut)
Side effects to remember:
EffectCauseKey point
Red Man SyndromeHistamine release from fast infusionNot a true allergy — just slow the drip
NephrotoxicityKidney damageMonitor drug levels
OtotoxicityEar damageEspecially with other ear-toxic drugs
Resistance (VRE): Bacteria change D-Ala–D-Ala → D-Ala–D-Lac, so vancomycin can't bind anymore.

🔬 Chapter 2: The Ribosome — The Bacteria's Protein Factory

Bacteria build proteins on 70S ribosomes (made of 30S + 50S subunits). Humans use 80S ribosomes. That size difference is the drug target.
Bacteria Ribosome (70S)
       |
   ┌───┴───┐
  30S     50S
   |       |
Tetra-   Macro-
cyclines  lides
Amino-   Clinda-
glyco-   mycin
sides    Linezolid
         Chloram-
         phenicol

🟨 Aminoglycosides — "The 30S Killers" (Bactericidal)

How they work:
They grab onto the 30S subunit and cause the ribosome to misread the genetic code → produces faulty proteins that poke holes in the bacterial membrane → more drug rushes in → kills bacteria.
Examples: Gentamicin, Tobramycin, Amikacin, Streptomycin
Spectrum: Aerobic gram-negative bacteria (E. coli, Pseudomonas, Klebsiella); synergistic with beta-lactams against enterococci.
Big side effects (the two nephro-oto duo):
ToxicityDetail
NephrotoxicityKidney damage — monitor creatinine
OtotoxicityEar damage (hearing loss / balance) — often permanent
Dosing trick: Once-daily dosing is preferred — the drug kills better at high concentrations (concentration-dependent) and the bacteria stay dead for a while after drug is gone (post-antibiotic effect).

🟨 Tetracyclines — "The 30S Brakes" (Bacteriostatic)

How they work:
They park on the 30S subunit and block new amino acids from entering the protein-building chain — like blocking a conveyor belt. Bacteria don't die immediately; they just can't grow.
💡 Bacteriostatic vs. Bactericidal: Bactericidal = kills bacteria. Bacteriostatic = stops bacteria from growing (your immune system finishes the job). For most infections either works — but in immunocompromised patients or serious infections (endocarditis, meningitis), you want bactericidal drugs.
DrugBest known for
DoxycyclineThe workhorse — Lyme disease, atypical pneumonia (Mycoplasma, Chlamydia), RMSF (Rocky Mountain Spotted Fever), malaria prophylaxis, acne
MinocyclineMRSA skin infections, acne
TigecyclineIV only; MDR bacteria (MRSA, VRE) — broad spectrum
Key rules:
  • ❌ Avoid in children < 8 years (stains developing teeth yellow, deposits in bones)
  • ❌ Avoid in pregnancy (same reason)
  • ❌ Don't take with milk, antacids, iron supplements — divalent metals bind the drug and prevent absorption (chelation)
  • ✅ Take doxycycline with a full glass of water and stay upright (can cause esophageal ulcers)

🟧 Macrolides / Azalides — "The 50S Cloggers" (Bacteriostatic)

How they work:
They attach to the 50S subunit and physically block the ribosome's exit tunnel — like putting a cork in a pipe. New proteins can't be elongated.
DrugKey features
ErythromycinOriginal macrolide; causes GI cramps (stimulates gut motility); many drug interactions
ClarithromycinBetter GI tolerance; used in H. pylori treatment (triple therapy) and MAC prophylaxis in HIV
Azithromycin (Z-pack)The most used macrolide; concentrates inside cells; 5-day course; Chlamydia (single 1g dose); atypical pneumonia
Best use: Atypical organisms — Mycoplasma, Chlamydia, Legionella (these bacteria hide inside cells and lack cell walls, so beta-lactams don't work).
Side effect alert: QT prolongation → cardiac arrhythmia risk (especially with other QT-prolonging drugs).

🟧 Clindamycin — "The Anaerobe Killer"

  • Also binds 50S
  • Spectrum: Gram-positive cocci + anaerobes (bacteria that live without oxygen, like in abscesses, aspiration pneumonia, pelvic infections)
  • Famous side effect: Associated with C. difficile colitis (it wipes out normal gut bacteria, allowing C. diff to take over)

🟧 Linezolid — "The Unique 50S Blocker"

Unique mechanism: Blocks the assembly of the ribosome itself (prevents 30S + 50S from joining → no 70S → no protein synthesis). No other drug does this → no cross-resistance.
Uses: MRSA, VRE — when vancomycin fails or can't be used.
Side effects:
  • 🩸 Thrombocytopenia (low platelets) with prolonged use
  • 😵 Serotonin syndrome if combined with SSRIs/SNRIs (because it inhibits MAO)
  • 👁️ Optic neuritis / peripheral neuropathy (long courses)

💊 Chapter 3: DNA & RNA — Attacking the Genetic Machinery


🟥 Fluoroquinolones — "The Topoisomerase Trappers" (Bactericidal)

How they work:
Bacterial DNA is a giant, tangled rope. Bacteria use special scissors called topoisomerases (gyrase and topoisomerase IV) to untangle it so it can be copied. Fluoroquinolones jam these scissors open → DNA strands snap → bacteria dies.
GenerationDrugRemember it for
2ndCiprofloxacinGram-negatives, Pseudomonas, UTI, anthrax
3rdLevofloxacin"Respiratory FQ" — pneumonia, gram-positives + gram-negatives
4thMoxifloxacinAdds anaerobes; best for pneumonia; not for UTI (doesn't concentrate in urine)
⚠️ Famous side effects (FDA black box warnings):
EffectClue
Tendon rupture (Achilles)Especially elderly, steroid users, kidney disease
QT prolongationCardiac arrhythmia
CNS effectsSeizures, confusion, especially in elderly
C. diffLike all antibiotics
Avoid in childrenDamages cartilage in developing joints

🟥 Rifampin — "The RNA Polymerase Blocker"

How it works: Directly plugs into bacterial RNA polymerase → no mRNA made → no proteins → bacteria dies.
Uses: TB (always in combination), leprosy, meningococcal prophylaxis, MRSA (adjunctive).
⚠️ Key point: Rifampin is a super CYP inducer → speeds up metabolism of dozens of drugs (oral contraceptives, warfarin, HIV drugs, etc.) → those drugs stop working. Always check drug interactions.
Fun fact: Turns body fluids (urine, sweat, tears) orange-red — warn patients about this!

🟥 Sulfonamides + Trimethoprim (TMP-SMX) — "The Folate Killers"

The concept: Bacteria must make their own folate (a vitamin needed to build DNA). Humans absorb folate from food and don't make it.
Bacteria's folate pathway:
PABA → [Dihydropteroate synthase] → Dihydrofolate → [Dihydrofolate reductase] → Tetrahydrofolate (THF)
          ↑                                                      ↑
    Sulfonamides block here                           Trimethoprim blocks here
Blocking TWO steps in the same pathway = synergistic (1+1 = 3 effect) — far more effective together.
Co-trimoxazole (TMP-SMX / Bactrim) uses:
  • UTI (oral — outpatient)
  • PCP (Pneumocystis jirovecii pneumonia — most common opportunistic infection in AIDS)
  • Nocardia, Toxoplasma prophylaxis
Side effects: Rash, Stevens-Johnson syndrome (severe skin reaction), hemolytic anemia in G6PD deficiency, kidney toxicity.

🟥 Metronidazole (Flagyl) — "The Anaerobic Assassin"

How it works: Gets inside bacteria/parasites → their enzymes activate metronidazole into toxic free radicals → shreds DNA.
The catch: Only anaerobic (low-oxygen) environments activate it properly → it's selective for anaerobes and parasites.
Uses: C. difficile (oral/IV), anaerobic abscesses, Giardia, Trichomonas, H. pylori (triple therapy), Entamoeba.
⚠️ Rule #1: No alcohol during or 48h after use — causes disulfiram-like reaction (flushing, vomiting, rapid heart rate).

🏥 Chapter 4: The Cell Membrane Disruptors

Daptomycin — "The Depolarizer"

  • A lipopeptide that inserts into gram-positive membranes → makes pores → ions leak → membrane potential lost → cell dies
  • MRSA, VRE bacteremia and endocarditis
  • ⚠️ INACTIVATED by lung surfactant → NEVER use for pneumonia
  • Monitor CPK (can cause muscle breakdown)

Polymyxins (Colistin, Polymyxin B) — "The Last Resort"

  • Detergent-like action on gram-negative outer membrane → disrupts it like soap dissolves grease
  • Reserved for highly drug-resistant gram-negative bacteria (Acinetobacter, Pseudomonas, KPC-Klebsiella)
  • Severely nephrotoxic

PART 2: ANTIMYCOBACTERIALS

🦠 Tuberculosis — RIPE Regimen

TB is caused by Mycobacterium tuberculosis — a very tough, slow-growing bacterium with a thick waxy coat. You need 4 drugs together for 6 months because:
  1. Single drugs → rapid resistance emergence
  2. Different drugs target different sub-populations of bacteria (fast-growing, slow-growing, dormant)
DrugWhat it doesUnique side effectMemory hook
RifampinBlocks RNA polymeraseOrange secretions, liver toxicity, drug interactionsRed/orange urine
Isoniazid (INH)Blocks mycolic acid synthesis (the waxy coat)Peripheral neuropathy → give B6 (pyridoxine) to prevent; hepatotoxicityINH → Inhibits the wax coat
PyrazinamideDisrupts bacterial membrane potentialHyperuricemia (gout!), hepatotoxicityPyrazine → Pain in the joints (gout)
EthambutolBlocks cell wall (arabinosyltransferase)Optic neuritis → monitor vision!Ethambutol → Eyes
Regimen: 2 months of RIPE → then 4 months of RI (continuation phase)

PART 3: ANTIVIRALS

🦠 First, understand viruses

Viruses are not alive in the traditional sense — they're genetic material (DNA or RNA) wrapped in a protein coat. They hijack your own cells to replicate. This is why antivirals are harder to develop than antibiotics — targeting the virus risks harming the host cell machinery.
The key: viruses encode a few unique enzymes (polymerases, proteases, integrases) that differ enough from human enzymes to target.

💊 Anti-Herpetics (HSV, VZV, CMV)

The acyclovir family — "The Trojan Horse Nucleosides"

How acyclovir works (step by step):
  1. Acyclovir enters both infected and uninfected cells
  2. In virus-infected cells, viral thymidine kinase phosphorylates it (activates it) → human enzymes don't do this step efficiently → selectively activated in infected cells
  3. Activated acyclovir → incorporated into viral DNA → acts as a chain terminator (DNA can't extend further) → viral replication stops
This selectivity is why acyclovir has minimal toxicity to normal cells.
DrugUseNotes
AcyclovirHSV-1/2 (cold sores, genital herpes, encephalitis), VZV (chickenpox, shingles)IV for severe disease; oral for suppression
ValacyclovirSame — prodrug of acyclovir with much better oral absorptionMost common oral form today
GanciclovirCMV (cytomegalovirus) — retinitis in AIDS, transplant patientsMyelosuppression (bone marrow suppression)
ValganciclovirCMV — oral prodrug of ganciclovirTransplant prophylaxis
FoscarnetResistant CMV and HSVWorks WITHOUT needing viral kinase activation → use when kinase is mutated; nephrotoxic

💊 Anti-Influenza

DrugMechanismNotes
Oseltamivir (Tamiflu)Blocks neuraminidase → virus can't release from cell surface → can't spreadFlu A & B; must start within 48 hours of symptoms
Zanamivir (Relenza)Same; inhaledCaution in asthma
BaloxavirBlocks cap-dependent endonuclease (a completely new target)Single oral dose; newest flu drug
💡 Neuraminidase analogy: Imagine the virus is a ball covered in sticky glue. Neuraminidase is the enzyme that cuts the glue so the virus can leave the cell surface and go infect new cells. Blocking neuraminidase = the virus gets stuck.

💊 HIV / Antiretrovirals (ART)

The HIV Life Cycle = Your Drug Target Map

HIV Life Cycle & Where Drugs Strike:

1. HIV attaches to CD4 + CCR5/CXCR4 on T-cell
          ↑ blocked by → Maraviroc (CCR5 antagonist)

2. Fusion of virus with cell membrane
          ↑ blocked by → Enfuvirtide (fusion inhibitor)

3. RNA → DNA via Reverse Transcriptase
          ↑ blocked by → NRTIs (Tenofovir, Zidovudine, Emtricitabine...)
          ↑ blocked by → NNRTIs (Efavirenz, Nevirapine, Rilpivirine...)

4. Viral DNA integrates into host chromosome
          ↑ blocked by → INSTIs (Dolutegravir, Bictegravir, Raltegravir)

5. New viral proteins made and cut by Protease
          ↑ blocked by → Protease Inhibitors (Darunavir, Ritonavir...)

6. Mature virus buds out and infects new cells

Drug Classes in Simple Terms:

ClassNicknameKey DrugsKey Toxicity
NRTIs"Fake nucleotides"Tenofovir, Emtricitabine, Abacavir, Zidovudine (AZT)Tenofovir: kidney/bone damage; AZT: anemia; Abacavir: check HLA-B*5701 first (fatal hypersensitivity)
NNRTIs"Allosteric RT blockers"Efavirenz, Nevirapine, RilpivirineEfavirenz: vivid dreams, dizziness, teratogenic; Nevirapine: liver toxicity, rash
PIs"Protease blockers"Darunavir, Atazanavir (+ Ritonavir as booster)Lipodystrophy (fat redistribution), dyslipidemia, hyperglycemia
INSTIs"Integrase blockers"Dolutegravir, BictegravirBest-tolerated; Dolutegravir: neural tube defect concern in early pregnancy
Fusion inhibitor"Locks the door"EnfuvirtideSC injection only; injection site reactions
CCR5 antagonist"Blocks the key"MaravirocRequires tropism testing first
Current standard regimen: Usually 2 NRTIs + 1 INSTI (e.g., Bictegravir/Tenofovir/Emtricitabine = Biktarvy — one pill, once daily).

PART 4: ANTIFUNGALS

🍄 Why Fungi Are Hard to Treat

Fungi are eukaryotes — just like us. They have a nucleus, mitochondria, and similar cell machinery. Targeting fungi without harming human cells is difficult.
The main exploitable difference: Fungi have ergosterol in their membranes (we have cholesterol). Most antifungals target ergosterol.

The Antifungal Ladder (from narrow to broad):

🔵 Polyenes — "The Ergosterol Punchers"

Amphotericin B:
  • Directly binds ergosterol → punches holes in the membrane → ions leak → fungi die
  • Broadest spectrum antifungal — works on Aspergillus, Candida, Cryptococcus, Histoplasma, Mucor
  • "The gold standard" — and also the most toxic
FormToxicity
Amphotericin B deoxycholate (conventional)Severe nephrotoxicity, hypokalemia, "shake and bake" infusion reactions (fever, rigors, hypotension)
Liposomal Amphotericin B (AmBisome)Same efficacy, much less nephrotoxicity — preferred when kidneys are at risk
Nystatin: Same mechanism — but too toxic for IV use; only topical/oral for Candida (thrush, vaginal, skin).

🟢 Azoles — "The Ergosterol Thieves"

Rather than punching holes in the wall, azoles stop fungi from making ergosterol in the first place.
Mechanism: Block CYP51 (lanosterol 14α-demethylase) → ergosterol depleted → toxic sterols accumulate → membrane dysfunction.
💡 Analogy: If ergosterol is the bricks in a wall, azoles prevent the brickyard from making bricks.
DrugBest forWatch out for
FluconazoleCandida (UTI, oral thrush, vaginal, systemic), Cryptococcal meningitis (maintenance)Weak azole (not for Aspergillus); drug interactions (CYP inhibitor)
ItraconazoleHistoplasma, Blastomyces, dermatophytesNeeds acid to absorb; avoid in heart failure (negative inotrope)
VoriconazoleAspergillus (drug of choice)Visual hallucinations/photopsia, hepatotoxicity, phototoxicity
PosaconazoleAspergillus + Mucorales (the only azole!)Prophylaxis in neutropenic patients; needs fatty meal for suspension
IsavuconazoleAspergillus, MucoralesFewer interactions; uniquely shortens QTc

🟡 Echinocandins — "The Cell Wall Demolishers"

Unique mechanism: Block β-(1,3)-D-glucan synthase — an enzyme that builds the fungal cell wall (fungi have a cell wall; humans don't → great selectivity!).
DrugNotes
CaspofunginIV; first-line for invasive Candida and salvage for Aspergillus
MicafunginIV; preferred for Candida prophylaxis in transplant patients
AnidulafunginIV; fewest drug interactions
Advantages: Low toxicity, minimal drug interactions, can use in renal failure. Disadvantages: IV only, no CNS penetration (can't treat Cryptococcal meningitis), expensive.

🟠 Allylamines — "The Nail Infection Drugs"

Terbinafine: Blocks squalene epoxidase → squalene accumulates (toxic) + ergosterol depleted → fungicidal.
  • Best for dermatophytes (tinea unguium/onychomycosis — nail fungus, ringworm)
  • Oral form for nail infections (topical penetrates poorly)

🔴 Flucytosine (5-FC) — "The DNA Wrecker"

  • Enters fungi → converted to 5-fluorouracil (5-FU) → disrupts DNA and RNA synthesis
  • NEVER use alone (resistance develops rapidly)
  • Combined with Amphotericin B for Cryptococcal meningitis (synergistic)
  • Side effects: Myelosuppression, hepatotoxicity

PART 5: ANTIPARASITICS

🦟 Antimalarials

First, understand the parasite's life cycle — it matters for treatment

Mosquito bites → Sporozoites injected → Travel to LIVER
     → Live in liver silently (hypnozoites in P. vivax/ovale)
         → Release merozoites into BLOOD → Invade red blood cells
             → Grow and burst RBCs (fever every 48-72h)
                 → Some become gametocytes → Mosquito picks them up
Key insight: Some drugs kill blood-stage parasites (treat the fever) but don't kill liver hypnozoites → the infection can relapse months/years later. You need primaquine to kill the liver stage.
DrugStage killedKey toxicityMemory
ChloroquineBlood stageRetinopathy (chronic), QT prolongationMost P. falciparum resistant; still good for P. vivax/ovale/malariae
PrimaquineLiver stage (hypnozoites)Hemolysis in G6PD deficiencyalways screen first!"P for primaquine, P for preventing relaPse"
Artesunate / ArtemisininBlood stage (most potent)Well toleratedDrug of choice for severe P. falciparum
MefloquineBlood stageNeuropsychiatric (nightmares, psychosis, hallucinations)"Mefloquine = Mental side effects"
Atovaquone-Proguanil (Malarone)Blood stage + liverGI side effectsBest tolerated prophylaxis drug
DoxycyclineBlood stage (adjunct)Photosensitivity, esophagitisCheap prophylaxis in endemic areas

🦠 Antiprotozoals

OrganismDrugMechanism
GiardiaMetronidazole / TinidazoleFree radical DNA damage
TrichomonasMetronidazole (treat partner too!)Same
Entamoeba histolyticaMetronidazole + ParomomycinMetronidazole for invasive; paromomycin for luminal
ToxoplasmaPyrimethamine + Sulfadiazine + LeucovorinBlock folate × 2; leucovorin protects human cells
PCP (Pneumocystis)TMP-SMX (1st line) / Pentamidine (alternative)Folate inhibition / disrupts DNA

🪱 Anthelmintics (Worm Drugs)

DrugMechanism (simple)Use
Albendazole / MebendazoleDestroy the worm's skeleton (block tubulin) → worm can't move or absorb glucoseRoundworms, hookworms, pinworms, Neurocysticercosis (brain tapeworm), echinococcosis
IvermectinHyper-activates GABA → worm is paralyzedOnchocerciasis (river blindness), Strongyloides, scabies, head lice
PraziquantelFloods worm with Ca²⁺ → muscle spasm → parasite is killed/expelledSchistosomiasis, tapeworms, liver flukes
Diethylcarbamazine (DEC)Immobilizes microfilariae for immune clearanceLymphatic filariasis (elephantiasis)

📊 Master Summary Table

DrugTargetBacteria/OrganismMechanism in 5 words
PenicillinCell wallGram-positive, strepBlocks PBP, wall breaks
VancomycinCell wallMRSA, gram-positiveBlocks D-Ala-D-Ala bricks
Gentamicin30S ribosomeGram-negativeMisreads mRNA, kills
Doxycycline30S ribosomeBroad (atypicals, tick)Blocks tRNA entry
Azithromycin50S ribosomeAtypicals, gram-positiveBlocks peptide elongation
CiprofloxacinDNA gyraseGram-negativeTraps topoisomerase, DNA breaks
RifampinRNA polymeraseTB, gram-positiveBlocks RNA synthesis
TMP-SMXFolate pathwayUTI, PCPBlocks folate × 2 steps
MetronidazoleDNAAnaerobes, protozoaFree radicals shred DNA
AcyclovirViral DNA polHSV, VZVChain termination, stops DNA
OseltamivirNeuraminidaseInfluenza A & BVirus can't escape cell
DolutegravirIntegraseHIVPrevents DNA integration
Amphotericin BErgosterolFungi (broad)Punches holes in membrane
FluconazoleCYP51CandidaStops ergosterol synthesis
Caspofunginβ-glucan synthaseCandida, AspergillusBreaks fungal cell wall
ChloroquineHeme polymeraseMalaria (blood stage)Toxic heme accumulates
PrimaquineMitochondriaLiver hypnozoitesRadical cure of P. vivax/ovale
AlbendazoleTubulinWormsParalyzes worm's skeleton
IvermectinGABA channelsWorms, ectoparasitesParalyzes the worm

🧠 The Beginner's 10 Rules to Remember

  1. Target the difference — every drug exploits something the microbe has but humans don't
  2. Bactericidal kills; bacteriostatic stops growth — immune system does the rest
  3. Beta-lactams = cell wall — all share the ring, all block PBP
  4. Ribosome size matters — 30S drugs (aminoglycosides, tetracyclines) and 50S drugs (macrolides, linezolid, clindamycin) won't touch human 80S ribosomes
  5. Never monotherapy for TB or HIV — resistance emerges instantly
  6. Check G6PD before primaquine, dapsone, nitrofurantoin — hemolytic anemia risk
  7. Check HLA-B*5701 before Abacavir — can be fatal
  8. Rifampin induces CYP enzymes — always check interactions
  9. No alcohol with metronidazole — disulfiram-like reaction
  10. Amphotericin B = broadest antifungal, most toxic — liposomal form is kinder to kidneys

Sources: Katzung's Basic & Clinical Pharmacology 16e; Jawetz Melnick & Adelberg's Medical Microbiology 28e; Lippincott Illustrated Reviews: Pharmacology
This is a shared conversation. Sign in to Orris to start your own chat.